Viewing Study NCT01302860


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2025-12-27 @ 11:06 PM
Study NCT ID: NCT01302860
Status: COMPLETED
Last Update Posted: 2017-03-29
First Post: 2011-02-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-11
Start Date Type: None
Primary Completion Date: 2014-11
Primary Completion Date Type: ACTUAL
Completion Date: 2014-11
Completion Date Type: ACTUAL
First Submit Date: 2011-02-22
First Submit QC Date: None
Study First Post Date: 2011-02-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-07-22
Results First Submit QC Date: None
Results First Post Date: 2015-08-18
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-02-28
Last Update Post Date: 2017-03-29
Last Update Post Date Type: ACTUAL